We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-0.31%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$111B
AUM Growth
+$1.46B
Cap. Flow
+$2.6B
Cap. Flow %
2.33%
Top 10 Hldgs %
23.97%
Holding
4,345
New
253
Increased
2,150
Reduced
1,535
Closed
239

Sector Composition

Rank Sector Weight
1 Technology 14.74%
2 Financials 9%
3 Healthcare 8.22%
4 Consumer Discretionary 6.53%
5 Industrials 6.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTBL
3951
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$26K ﹤0.01%
362
CB icon
3952
CALL
Chubb
CB
$134B
$25K ﹤0.01%
44,100
-3,700
-8% -$649K
MPLX icon
3953
CALL
MPLX
MPLX
$60.1B
$25K ﹤0.01%
46,200
OMC icon
3954
CALL
Omnicom Group
OMC
$23.6B
$25K ﹤0.01%
44,900
+11,300
+34% +$840K
AGRX
3955
DELISTED
Agile Therapeutics
AGRX
$25K ﹤0.01%
13
EQX icon
3956
CALL
Equinox Gold
EQX
$13.5B
$24K ﹤0.01%
78,200
+52,500
+204% +$353K
NGD
3957
DELISTED
New Gold Inc
NGD
$24K ﹤0.01%
22,704
-67,732
-75% -$93.1K
NXE icon
3958
CALL
NexGen Energy
NXE
$7.07B
$24K ﹤0.01%
+16,000
New +$70.7K
QNTM
3959
Quantum Biopharma Class B Subordinate Voting Shares
QNTM
$23.4M
$24K ﹤0.01%
231
QTNT
3960
DELISTED
Quotient Limited Ordinary Shares
QTNT
$24K ﹤0.01%
259
-227
-47% -$28.4K
CTXR icon
3961
Citius Pharmaceuticals
CTXR
$20.1M
$23K ﹤0.01%
463
+3
+0.7% +$151
CWBR
3962
DELISTED
CohBar, Inc. Common Stock
CWBR
$23K ﹤0.01%
814
C icon
3963
CALL
Citigroup
C
$228B
$22K ﹤0.01%
19,400
+800
+4% +$55.9K
EDU icon
3964
New Oriental
EDU
$8.82B
$22K ﹤0.01%
1,064
-20,416
-95% -$648K
B
3965
CALL
Barrick Mining
B
$67.3B
$22K ﹤0.01%
170,000
+6,100
+4% +$122K
KMI icon
3966
CALL
Kinder Morgan
KMI
$70.1B
$22K ﹤0.01%
50,200
-3,800
-7% -$64.6K
PENN icon
3967
CALL
PENN Entertainment
PENN
$2.56B
$22K ﹤0.01%
+16,800
New +$1.23M
HBI
3968
CALL
DELISTED
Hanesbrands
HBI
$21K ﹤0.01%
286,600
+20,300
+8% +$381K
MDXG icon
3969
CALL
MiMedx Group
MDXG
$627M
$21K ﹤0.01%
40,000
+20,000
+100% +$225K
VZ icon
3970
CALL
Verizon
VZ
$196B
$21K ﹤0.01%
132,400
-63,800
-33% -$3.53M
CSLT
3971
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$21K ﹤0.01%
13,400
+2,400
+22% +$4.7K
CME icon
3972
CALL
CME Group
CME
$93.2B
$19K ﹤0.01%
18,500
-16,600
-47% -$3.36M
GSK icon
3973
CALL
GSK
GSK
$102B
$19K ﹤0.01%
77,040
+1,040
+1% +$52.2K
OPFI.WS
3974
DELISTED
OppFi Inc Warrants
OPFI.WS
$19K ﹤0.01%
+12,237
New +$19.1K
ATHX
3975
DELISTED
Athersys, Inc. Common Stock
ATHX
$19K ﹤0.01%
564
-158
-22% -$6K

Similar funds

Raymond James & Associates's Q3 2021 Portfolio in Review

As of Q3 2021, Raymond James & Associates held 4,345 positions worth $111B, up 1.3% from $110B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q3 2021 filing shows 253 new, 2,150 increased, 1,535 reduced and 239 closed positions. Its largest new stake was GXO Logistics: 224,392 shares worth $17.6M. The largest sale was iShares Core S&P Mid-Cap ETF, an estimated $358M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q3 2021 buy was GXO Logistics: 224,392 shares worth $17.6M.
  • Raymond James & Associates added most to Vanguard Morningstar Mid-Cap ETF in Q3 2021, an estimated $569M increase.
  • Raymond James & Associates's biggest Q3 2021 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $358M.
  • Raymond James & Associates fully exited Invesco S&P 500 Equal Weight Energy ETF in Q3 2021, selling an estimated $9.16M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $111B portfolio in Q3 2021.
  • Raymond James & Associates opened 253 new positions and closed 239 in Q3 2021.
  • Raymond James & Associates's portfolio value rose 1.3% quarter-over-quarter to $111B.

Based on Raymond James & Associates's 13F filing for Q3 2021, filed 2 Nov 2021.